MEDAIOO Health EDC

From Asia & Switzerland.
New Therapies. For you©

We are commercial, medical & IP experts with multiple success projects & stories. Our mission is to bring innovative, partly breakthrough medicines from Asia (e.g. China, South Korea) or the world into Europe and Switzerland, international markets and to the Americas. With legal structures, patents / IP and taxation – managed in Switzerland for the world – in a lean, successful way

We are equally an EDC – an Ethics Driven Company.

New Commercial Models in Europe & International

We have built new European presences
for leading and mid-sized, global companies from the
beginning for Europe, International Markets, USA & Canada

Anti Infectives

CUBIST (acquired by Merck & Co.)

Inflammation & Rheumatology

BIOGEN Biosimilars (anti-TNFs, derma-tology, rheumatology, gastroenterology)

Oncology

ONYX (acquired by Amgen Inc.)

Nephrology

RETROFIN Inc.

Serono Hormones

MS / CNS, growth hormones, oncology (acquired by Merck Darmstadt)

Animal Health

ANNIMOO, immuno-oncology for horses, camels, dogs & cats, Europe, MEA, Americas

Partners, direct contacts with major companies, and one coordinating partner for Asia:

INVEST HONG KONG

http://www.investhk.gov.hk

With MEDAIOO ©, you build your presence with us for Europe, MEA and Eastern Europe, Canada & the Americas (“International Markets”). You use legal, established Swiss structures and legal entities paired with European commercial experience for European, international and global sales excellence via Switzerland. You can integrate at a later stage or – expand further through your partners in Switzerland. Whatever you like and prefer.

Your business will be built with high quality, true excellence, at low costs, AI driven, by an international team of commercialisation and medical experts for Europe and International. We adopt and tailor the pioneering, AZ, 1st global multi-channel model in medical and commercial for your products. It has shown highest launch success and market shares across Europe and International – with a strong patient focus – at far lower costs for your business.

Strong IP and patent management for your products are assured – with the intended “Swiss Patent Box” status for international sales wherever possible

Leading Edge Commercial & IP management

Track record of building European & International Businesses

Trust. Team knowing each other

Specialists in medical and corporate, AI 360 governance for great brand building

Excellence in Legal / IP, Commercial Build Ups

Our medical & commercial framework has been industry leading across Europe in the late 2010’s until today. We developed the 1st multi channel commercial organisation in biopharma / healthcare across Europe. Consultants were helping and learning and took the concept into our industry. We now included AI support in all aspects and could further increase the effectiveness of our “NEMOO Omni-Channel” solution – also for patients.

4 Simple Phases for your solution finding for European & International Markets

Find your best solution for Europe & International

Contact Us & Appointment

Just reach out. We are happy to help.

Evaluate Options

We discuss the different options, way forward

Evaluate financially best 2-3 options

Together, we run all numbers, your perspective

Deal making &
build up together

We agree, sleep over it and seal our joint cooperation

Our innovative, commercial model in Europe, EMEA and International Markets

We built our model jointly at AstraZeneca, optimised it further (incl. AI) and implemented it successfully in another 7 to 9 companies thereafter

AstraZeneca Austria & Mid Sized Markets, Europe / EE

Tested, implemented, fine-tuned the 1st biopharma Multi-Channel Selling Model in biopharma industries


AstraZeneca EMEA & International Markets

Transformation to Multi Channel of entire EMEA region, 8.5 bn USD in revenues and International Markets


Biogen Biosimilars, Cubist, Shire, Pfizer, Merck, …

Multi-Channel & medical & commercial innovative setups for many other companies – “it works basically everywhere”


Successful commercial build ups “Multi Channel Biopharma (AZ+)”

countries with successful new build up’s for product launches

customer target audiences with high quality approaches

of clients and patients served exceeding “very high” satisfaction scores

“Patient Focus is helping us after medical launches to treat more patients with greater ease – achieving better outcomes.”

After medical and scientific launches, we focus a lot on the patient servicing side through the caregivers and treating physicians. This creates value to all persons involved – and ultimately makes us all succeed in our different roles.

“I appreciate their medical and patient focus after the introduction. It helps me succeed with more patients at the same time.”

Interventional Cardiologist

Physician

“It is much fun to work as a patient focused representative. I was a nurse before and appreciate helping many professionals giving the best care to their patients … daily.”

Patient Service Team

Representative

This is a dream team coming together again. I wish our pioneering AZ colleagues from 2010+ best of luck in their endeavours.

Regional Head, Europe

Executive biopharma

“I came from another company to learn this customer and patient centric model. Today, I am a national sales manager and business unit head, applying the same principles. They do work everywhere.”

Team & Business Unit Head DACH

Manager

Positive contributions to patients, commercial and financial success (EV, EBITA)

The combination of a highly effective, very cost sensitive, commercial model with IP, strong “AI 360” skills led by experienced management is assuring value for all stakeholders especially our companies, partners and multiple investors